Forte Biosciences: Glazer Capital reports 0% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Forte Biosciences, Inc. (FBRX) is identified in an amended ownership report in which Glazer Capital, LLC and its managing member, Paul J. Glazer, each report beneficial ownership of 0 shares of common stock, or 0% of the class. Glazer Capital says it filed with respect to shares held by funds and managed accounts it manages; the statement says the report is not an admission that either reporting person is a beneficial owner under Section 13 of the Act.
Key Figures
Key Terms
beneficial owner regulatory
dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.